Diagnosis and Management of Testicular Cancer

Part I: Overview of the latest recommendations of the European Germ Cell Cancer Group.- Part II: Special topics about controversial aspects, new results from studies, which might change treatment recommendations and long-term-survivorship: Is there still an indication for radiotherapy in seminoma CS I/ IIA/B?- How should we treat nonseminoma CSI?.- Is there still an indication for diagnostic RPLND in nonseminoma CSI?.- How could the prognosis of patients with intermediate risk disease be improved?.- How should patients with poor-prognosis disease be treated actually?.- How should patients with recurrent disease be treated actually?.- How important are prognostic factors for determining treatment in patients with primary or recurrent disease?.- What should be the boundaries in retroperitoneal residual tumor resection in nonseminoma?.- How should residual disease outside the retroperitoneum be treated?.- What are the recent recommendations for follow up in testicular cancer?.- What are the long-term toxicities to be controlled and treated?.- Consequences of the disease and its treatment concerning sexuality and fertility.

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Cirurgia oncológica
• Urologia e medicina urológica
• Oncologia

Classification of testicular tumors;Diagnosis of testicular tumors;Follow-up in testicular cancer;Long-term survivorship;Stage-dependent treatment of testicular tumors;Radiaton Oncology